Cargando…
Adverse Events of Latent Tuberculosis Treatment With Isoniazid in People Living With HIV: A Case-Control Study in a Resource-Rich Setting
Introduction Multiple risk factors, such as human immunodeficiency virus (HIV) infection and immunosuppressive therapies, increase the odds of latent tuberculosis infection (LTBI) reactivation and progression to active tuberculosis. A six-to-nine-month preventive treatment with isoniazid (INH) decre...
Autores principales: | Carlos Silveira Machado, António, Figueiredo, Cristóvão, Teixeira, Tiago, Azevedo, Carlos, Fragoso, Joana, Nunes, Sofia, Coutinho, Daniel, Malheiro, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412740/ https://www.ncbi.nlm.nih.gov/pubmed/37575717 http://dx.doi.org/10.7759/cureus.41647 |
Ejemplares similares
-
Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
por: Dhungana, Govinda Prasad, et al.
Publicado: (2019) -
Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study
por: Runels, Tessa, et al.
Publicado: (2022) -
Sex differences and adverse events of antiretrovirals in people living with HIV/AIDS: a systematic review and meta-analysis protocol
por: de Oliveira, Jardel Corrêa, et al.
Publicado: (2022) -
Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia
por: Gompels, U. A., et al.
Publicado: (2012) -
Adverse birth outcome case definitions associated with maternal HIV and antiretroviral drug use in pregnancy: a scoping review protocol
por: Dube, Kopano Rebaona, et al.
Publicado: (2023)